Related Experiment Video
Updated: Aug 18, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours
Simona Freddi1, Giorgio Arnaldi, Francesca Fazioli
1Division of Endocrinology, Institute of Clinical Medicine and Applied Biotechnology, Ancona, Italy.
Objective:
Several splice variants (SVs) of GHRH receptor (GHRH-R) have been identified in various human cancers through which GHRH antagonists may exert their IGF-II-mediated antiproliferative action. Because the overexpression of the IGF-II gene is a frequent feature of adrenal carcinoma, we searched for the presence of GHRH-R SVs in these tumours.
Methods And Results:
The expression of GHRH-R SVs was assessed by nested PCR in 45 human adrenocortical tumours. We have amplified 720-, 566- and 335-bp PCR products only in carcinomas. Their sequence revealed three open reading frames, corresponding to SV1, SV2 and SV4 of GHRH-R. SV2 was detected in five of 24 cancers examined, whereas the incidence of SV1 and SV4 was lower. Their simultaneous expression was observed in one carcinoma. No PCR products for SV3 or wild-type GHRH-R were found in carcinomas; mRNA for wild-type GHRH-R or SVs of GHRH-R were not observed either in adenomas or in normal adrenal or in NCI-H295R cells. Interestingly, all carcinomas which expressed SVs were also positive for the presence of GHRH mRNA.
Conclusion:
This is the first time that the expression of splice variants of GHRH-R has been demonstrated in human adrenal carcinoma. This study raises the possibility that splice variants might play a role in adrenal carcinogenesis and might offer the possibility for new therapeutic strategies at least in a subgroup of adrenal carcinomas.
Insights
The study found splice variants (SVs) of the GHRH receptor (GHRH-R) in human adrenal carcinomas, but not in normal adrenal tissue or adenomas. These GHRH-R SVs may offer new therapeutic targets for adrenal cancer.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Splice variants (SVs) of the GHRH receptor (GHRH-R) are implicated in cancer via IGF-II-mediated pathways.
- IGF-II gene overexpression is common in adrenal carcinoma.
Purpose of the Study:
- To investigate the presence of GHRH-R SVs in human adrenal carcinoma.
- To explore potential therapeutic strategies targeting GHRH-R SVs.
Main Methods:
- Nested PCR was used to detect GHRH-R SVs in 45 human adrenocortical tumors.
- Sequencing identified specific GHRH-R SVs (SV1, SV2, SV4) in carcinoma samples.
Main Results:
- GHRH-R SVs (SV1, SV2, SV4) were detected exclusively in adrenal carcinomas, not in adenomas or normal adrenal tissue.
- SV2 showed the highest incidence (5/24), with lower frequencies for SV1 and SV4.
- Carcinomas expressing GHRH-R SVs were also positive for GHRH mRNA.
Conclusions:
- This is the first demonstration of GHRH-R SV expression in human adrenal carcinoma.
- GHRH-R SVs may play a role in adrenal carcinogenesis.
- These findings suggest potential novel therapeutic avenues for a subset of adrenal carcinomas.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Mitogens and the Cell Cycle
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
